
Peptide appearance
Lyophilized form helps protect peptide quality. Peptides are supplied as a dry powder, which may look like a compact "puck" or a lighter powder inside the vial.
Because the peptide is dry, it does not require refrigerated shipping during normal transit, including warm seasonal conditions. For longer storage, follow the storage guidance in the product description.
Appearance can vary. The stated peptide content is checked through third-party analysis.
Read more in the product description.
Solution not bundled
Peptides are delivered as lyophilized powder. This dry form helps preserve peptide quality during storage and transport and does not require refrigerated shipping during normal transit.
To prepare a solution, use a solvent such as Bacteriostatic water. It is sold separately, so add it only when you need it for peptide preparation.
Read more in the product description.
Peptide blend
CJC-1295 + Ipamorelin
In stock
A two-component GHRH-analogue and secretagogue-peptide research blend.
Order within — · ships today Cutoff 10:00 · local time
Arrives Sep 21 - Sep 23 to Europe
CJC-1295 + Ipamorelin
Price range: 85,50 € through 129,90 €
CJC-1295 and Ipamorelin blend for paired GHRH and GHSR pathway studies.
Scroll horizontally to reach every product-information tab.
Research overview
CJC-1295 + Ipamorelin
CJC-1295 + Ipamorelin combines a GHRH-analogue material with the pentapeptide Ipamorelin.
The blend is interpreted through the declared amount and analytical identity of each component. The listed sources are a research starting point rather than a substitute for product evidence: the supplied material's exact form, lot, and measured characteristics must be established through its signed analytical record.
Compound information
Specifications
Molecular profile
- Sequence
- CJC-1295 no-DAC: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2; Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Molecular mass
- CJC-1295 no-DAC: 3367.9 g/mol; Ipamorelin: 711.9 g/mol.
- CAS number
- CJC-1295 no-DAC: 446036-97-1; Ipamorelin: 170851-70-4.
- Molecular formula
- CJC-1295 no-DAC: C152H252N44O42; Ipamorelin: C38H49N9O5.
Material record
- Physical appearance
- White to off-white lyophilized powder
- Solubility
- Soluble in bacteriostatic water and suitable aqueous laboratory solvents.
- Product note
- Two-component peptide blend; studied around GHRH and ghrelin receptor pathway models; supplied strictly for research use only.
Laboratory care
Handling
Peptides in transport
Peptides in lyophilized form are supplied in glass vials by standard shipping methods and do not require refrigeration. Short-term temperature fluctuations during transport will not reduce their quality and efficacy. Even at high summer temperatures, the peptides in lyophilized form are stable for several weeks.
Storage of lyophilized peptides
Lyophilized peptides should be stored in a dry place, protected from light and moisture. The following storage conditions are generally recommended:
- Room temperature (15–25 °C): Up to 3 months
- Refrigerated (2–8 °C): Up to 6 months
- Frozen (-20 °C or below): 3–5 years (recommended for long-term storage)
Allow the vial to reach room temperature after taking it out of the refrigerator or freezer.
Storage of reconstituted peptides
Once reconstituted, peptide solutions are generally less stable than their lyophilized form and should be stored under refrigerated conditions whenever possible.
The following storage conditions are generally recommended:
- Room temperature (15–25 °C): Avoid prolonged storage
- Refrigerated (2–8 °C): Typically 4–8 weeks
- Frozen (-20 °C or below): Up to 3–4 months
To preserve peptide integrity, avoid repeated freeze–thaw cycles, as these may accelerate peptide degradation.
Important: Most manufacturers recommend discarding reconstituted peptides within 4 weeks when stored at 2–8 °C. This recommendation is intentionally conservative and may not reflect the actual chemical stability of every peptide. In our own stability studies, many peptides reconstituted in bacteriostatic water showed no detectable degradation after 12 weeks of refrigerated storage. As peptide stability is highly sequence- and formulation-dependent, this result should not be extrapolated to all peptides without supporting stability data.
Analytical documentation
Latest test results
Latest published result
Liquilabs s.r.o.Signed Certificate of Analysis · 10mg+10mg
See reportPurity by HPLC
Recorded QC panel
- Ipamorelin AssayPeptide screening
- 11.47 mg
- MOD GRF (1-29) AssayPeptide screening
- 10.57 mg
- Ipamorelin PurityPeptide screening
- 99.7%
- MOD GRF (1-29) PurityPeptide screening
- 99.6%
- Ipamorelin Identity (FTIR)FTIR spectrum
- 996
- MOD GRF (1-29) Identity (FTIR)FTIR spectrum
- 994
- Ipamorelin Identity (RT)Retention time
- 0.992
- Bacterial EndotoxinUSP / Eur. Ph. 2.6.14
- 0.009 EU/mg
- Molecular Ion MassMS deconvolution
- 711 Da
- Molecular Ion MassMS deconvolution
- 3367 Da
These are the latest published results for this strength. The batch number is printed on each vial. Your supplied batch is confirmed against the matching published record when your order is allocated.
Latest published result
Liquilabs s.r.o.Signed Certificate of Analysis · 5mg+5mg
See reportPurity by HPLC
Recorded QC panel
- Ipamorelin AssayPeptide screening
- 5.63 mg
- MOD GRF (1-29) AssayPeptide screening
- 5.24 mg
- Ipamorelin PurityPeptide screening
- 99.4%
- MOD GRF (1-29) PurityPeptide screening
- 99.3%
- Ipamorelin Identity (FTIR)FTIR spectrum
- 995
- MOD GRF (1-29) Identity (FTIR)FTIR spectrum
- 994
- Ipamorelin Identity (RT)Retention time
- 0.989
- Bacterial EndotoxinUSP / Eur. Ph. 2.6.14
- 0.018 EU/mg
- Molecular Ion MassMS deconvolution
- 711 Da
- Molecular Ion MassMS deconvolution
- 3367 Da
These are the latest published results for this strength. The batch number is printed on each vial. Your supplied batch is confirmed against the matching published record when your order is allocated.
Source record
References
National Center for Biotechnology Information
PubChem Compound Summary: CJC-1295
Identity record for the CJC-1295 component.
PubChem · View source ↗National Center for Biotechnology Information
PubChem Compound Summary: Ipamorelin
Identity record for the Ipamorelin component.
PubChem · View source ↗Teichman SL, Neale A, Lawrence B, et al. · 2006
Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of growth hormone-releasing hormone, in healthy adults
Context for long-acting DAC CJC-1295 only; this paper does not establish which CJC form is present in the sold blend.
Journal of Clinical Endocrinology and Metabolism · 10.1210/jc.2005-1536 View source ↗Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA · 2006
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
The Journal of clinical endocrinology and metabolism · View source ↗Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH · 1998
Ipamorelin, the first selective growth hormone secretagogue
European journal of endocrinology · View source ↗Shrestha P, Sabharwal G, Ghaffari G · 2018
A Novel STAT3 Gene Mutation Related Hyper-IgE Syndrome Misdiagnosed as Hidradenitis Suppurativa
Case reports in immunology · View source ↗Sander HJ, Kramer P, van Leeuwen EC, van Cappellen WA, Meijs-Roelofs HM, De Jong FH · 1991
Ovulation rate, follicle population and FSH levels in cyclic rats after administration of an inhibin-neutralizing antiserum
The Journal of endocrinology · View source ↗Kallio P, Murphy ED · 1998
Soluble CD27 in thyroid disorders
The Journal of laboratory and clinical medicine · View source ↗Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, Dousset B, Bertagna X, Bertherat J · 2006



